Bragar Eagel & Squire, P.C. Investigates Sale of CCR and Encourages Investors to Contact the Firm
Click here to learn more and participate in the action.
On October 23, 2020, CCR announced that it had signed an agreement to be acquired by CEIX for approximately $34.4 million. Pursuant to the merger agreement, CCR stockholders receive 0.73 shares of CEIX common stock for each share of CCR common stock owned. The deal is expected to close in the first quarter of 2021.
Bragar Eagel & Squire is concerned that CCR’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for CCR’s stockholders.
If you own shares of CCR and are concerned about the proposed merger, or you are interested in learning more about the investigation or your legal rights and remedies, please contact Melissa Fortunato or Alexandra Raymond by email at email@example.com or telephone at (646) 860-9157, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Read More: Bragar Eagel & Squire, P.C. Investigates Sale of CCR and Encourages Investors to Contact the Firm